target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id GPR55,109,Q9Y2T6,Human,2-arachidonoylglycerol,729,,5282280,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(CO)CO,"InChI=1S/C23H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)27-22(20-24)21-25/h6-7,9-10,12-13,15-16,22,24-25H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15-",RCRCTBLIHCHWDZ-DOFZRALJSA-N,Agonist,Agonist,,yes,,,pEC50,,8.52,,EC50,,3.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,CP55940,730,,104895,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C,"InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3/t18-,20-,22-/m1/s1",YNZFFALZMRAPHQ-SYYKKAFVSA-N,Agonist,Agonist,,,,,pEC50,,8.3,,EC50,,5.0,,=,,,,17876302|16318877, GPR55,109,Q9Y2T6,Human,HU-210,731,,9821569,CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=CC1)CO)(C)C)(C)C,"InChI=1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m1/s1",SSQJFGMEZBFMNV-WOJBJXKFSA-N,Agonist,Agonist,,,,,pEC50,,7.59,,EC50,,26.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,[3H]CP55940,734,,104895,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C,"InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3/t18-,20-,22-/m1/s1",YNZFFALZMRAPHQ-SYYKKAFVSA-N,Agonist,Agonist,,,,,,,,,,,,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,AM281,741,,4302962,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCOCC1,"InChI=1S/C21H19Cl2IN4O2/c1-13-19(21(29)26-27-8-10-30-11-9-27)25-28(18-7-4-15(22)12-17(18)23)20(13)14-2-5-16(24)6-3-14/h2-7,12H,8-11H2,1H3,(H,26,29)",AJFFBPZYXRNAIC-UHFFFAOYSA-N,Antagonist,Antagonist,,,,,pIC50,8.52,,7.87,IC50,13.6,,3.0,=,,,,17876302|20136841, GPR55,109,Q9Y2T6,Human,rimonabant,743,,104850,Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1,"InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)",JZCPYUJPEARBJL-UHFFFAOYSA-N,Antagonist,Antagonist,,,,,pEC50,6.55,,5.26,EC50,5500.0,,280.0,=,,,,20136841|21233197, GPR55,109,Q9Y2T6,Human,[3H]rimonabant,745,,54585418,Clc1ccc(cc1)c1n(nc(c1C([3H])([3H])[3H])C(=O)NN1CCCCC1)c1ccc(cc1Cl)Cl,"InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)/i1T3",JZCPYUJPEARBJL-RLXJOQACSA-N,Agonist,Partial agonist,,,,,,,,,,,,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,anandamide,2364,,5281969,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO,"InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15-",LGEQQWMQCRIYKG-DOFZRALJSA-N,Agonist,Agonist,,yes,,,pEC50,,7.74,,EC50,,18.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,Δ9-tetrahydrocannabinol,2424,,16078,CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",CYQFCXCEBYINGO-IAGOWNOFSA-N,Agonist,Agonist,,,,,pEC50,,8.1,,EC50,,8.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,N-oleoylethanolamide,2661,,5283454,CCCCCCCC/C=C\CCCCCCCC(=O)NCCO,"InChI=1S/C20H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9-",BOWVQLFMWHZBEF-KTKRTIGZSA-N,Agonist,Agonist,,,,,pEC50,6.5,,6.25,EC50,565.0,,315.0,=,,,,17876302, GPR55,109,Q9Y2T6,Human,AM251,3317,,2125,Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1,"InChI=1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)",BUZAJRPLUGXRAB-UHFFFAOYSA-N,Agonist,Agonist,,,,,pEC50,7.41,,5.02,EC50,9600.0,,39.0,=,,,,17876302|20136841|19723626, GPR55,109,Q9Y2T6,Human,N-palmitoylethanolamine,3622,,4671,CCCCCCCCCCCCCCCC(=O)NCCO,"InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)",HXYVTAGFYLMHSO-UHFFFAOYSA-N,Agonist,Agonist,,yes,,,pEC50,,8.4,,EC50,,4.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,lysophosphatidylinositol,4028,,73755067,O[C@@H](COC(=O)C)COP(=O)(O[C@@H]1[C@H](O)[C@H](O)[C@H]([C@@H]([C@H]1O)O)O)O,"InChI=1S/C11H21O12P/c1-4(12)21-2-5(13)3-22-24(19,20)23-11-9(17)7(15)6(14)8(16)10(11)18/h5-11,13-18H,2-3H2,1H3,(H,19,20)/t5-,6-,7-,8+,9+,10+,11-/m0/s1",FBDBXJJQMHPGMP-IFUOQLDVSA-N,Agonist,Agonist,,yes,,,pEC50,7.31,,5.5,EC50,1000.0,,49.0,=,,,,17765871|20136841|23396314, GPR55,109,Q9Y2T6,Human,cannabidiol,4150,,644019,CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C,"InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1",QHMBSVQNZZTUGM-ZWKOTPCHSA-N,Antagonist,Antagonist,,,,,pIC50,6.46,,6.35,IC50,445.0,,350.0,=,,,,17876302|21079038, GPR55,109,Q9Y2T6,Human,O-1602,5525,,45073499,CC1=C[C@H]([C@@H](CC1)C(=C)C)c1c(C)cc(cc1O)O,"InChI=1S/C17H22O2/c1-10(2)14-6-5-11(3)7-15(14)17-12(4)8-13(18)9-16(17)19/h7-9,14-15,18-19H,1,5-6H2,2-4H3/t14-,15+/m0/s1",KDZOUSULXZNDJH-LSDHHAIUSA-N,Agonist,Agonist,,,,,pEC50,8.85,,7.89,EC50,13.0,,1.4,=,,,,10381763|17876302|21079038, GPR55,109,Q9Y2T6,Human,abnormal cannabidiol,5526,,89949,CCCCCc1cc(O)cc(c1[C@@H]1C=C(C)CC[C@H]1C(=C)C)O,"InChI=1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1",YWEZXUNAYVCODW-RBUKOAKNSA-N,Agonist,Agonist,,,,,pEC50,,8.6,,EC50,,2.5,,=,,,,17704827, GPR55,109,Q9Y2T6,Human,abnormal cannabidiol,5526,,89949,CCCCCc1cc(O)cc(c1[C@@H]1C=C(C)CC[C@H]1C(=C)C)O,"InChI=1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1",YWEZXUNAYVCODW-RBUKOAKNSA-N,Agonist,Agonist,,,,,pEC50,5.71,,5.51,EC50,3102.0,,1944.0,=,,,,17876302, GPR55,109,Q9Y2T6,Human,2-arachidonyl glyceryl ether,5545,,6483057,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCOC(CO)CO,"InChI=1S/C23H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26-23(21-24)22-25/h6-7,9-10,12-13,15-16,23-25H,2-5,8,11,14,17-22H2,1H3/b7-6-,10-9-,13-12-,16-15-",CUJUUWXZAQHCNC-DOFZRALJSA-N,Agonist,Agonist,,,,,pEC50,,8.0,,EC50,,10.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,O-arachidonoyl ethanolamine,5554,,5712057,CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCCN,"InChI=1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(24)25-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21,23H2,1H3/b7-6-,10-9-,13-12-,16-15-",DLHLOYYQQGSXCC-DOFZRALJSA-N,Agonist,Agonist,,,,,pEC50,,7.92,,EC50,,12.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,JWH015,5558,,4273754,CCCn1c(C)c(c2c1cccc2)C(=O)c1cccc2c1cccc2,"InChI=1S/C23H21NO/c1-3-15-24-16(2)22(20-12-6-7-14-21(20)24)23(25)19-13-8-10-17-9-4-5-11-18(17)19/h4-14H,3,15H2,1-2H3",LJSBBBWQTLXQEN-UHFFFAOYSA-N,Agonist,Agonist,,,,,pEC50,,8.4,,EC50,,4.0,,=,,,,17876302, GPR55,109,Q9Y2T6,Human,T1117,5560,,57369426,Clc1ccc(c(c1)Cl)n1nc(c(c1c1ccc(cc1)c1ccc(cc1)CCCNC(=O)c1ccc2c(c1)C(=O)OC12c2ccc(cc2Oc2c1ccc(c2)N(C)C)N(C)C)C)C(=O)NN1CCCCC1,"InChI=1S/C56H53Cl2N7O5/c1-34-51(54(67)61-64-28-7-6-8-29-64)60-65(48-26-20-40(57)31-47(48)58)52(34)38-17-15-37(16-18-38)36-13-11-35(12-14-36)10-9-27-59-53(66)39-19-23-44-43(30-39)55(68)70-56(44)45-24-21-41(62(2)3)32-49(45)69-50-33-42(63(4)5)22-25-46(50)56/h11-26,30-33H,6-10,27-29H2,1-5H3,(H,59,66)(H,61,67)",RNAPRXIZPJDYPH-UHFFFAOYSA-N,Agonist,Agonist,,,,,,,,,,,,,=,,,,20136833, GPR55,109,Q9Y2T6,Human,GSK575594A,5561,,59822766,Fc1ccc(cc1)c1ccc(cc1C(=O)N1CCN(CC1)c1ccc(cc1F)N)S(=O)(=O)C,"InChI=1S/C24H23F2N3O3S/c1-33(31,32)19-7-8-20(16-2-4-17(25)5-3-16)21(15-19)24(30)29-12-10-28(11-13-29)23-9-6-18(27)14-22(23)26/h2-9,14-15H,10-13,27H2,1H3",DAPKZHQMEQRNPY-UHFFFAOYSA-N,Agonist,Agonist,,,,,pEC50,,8.17,,EC50,,6.8,,=,,,,21233197, GPR55,109,Q9Y2T6,Human,GSK494581A,5562,,11855860,COC(c1ccc(c(c1)F)N1CCN(CC1)C(=O)c1cc(ccc1c1ccc(cc1)F)S(=O)(=O)C)C,"InChI=1S/C27H28F2N2O4S/c1-18(35-2)20-6-11-26(25(29)16-20)30-12-14-31(15-13-30)27(32)24-17-22(36(3,33)34)9-10-23(24)19-4-7-21(28)8-5-19/h4-11,16-18H,12-15H2,1-3H3",JQXZHDOSMUZLML-UHFFFAOYSA-N,Agonist,Agonist,,,,,pEC50,,8.19,,EC50,,6.5,,=,,,,21233197, GPR55,109,Q9Y2T6,Human,CID1792197,5563,,1792197,COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C,"InChI=1S/C24H23N3O4S2/c1-27(20-9-4-3-5-10-20)33(29,30)21-15-13-19(14-16-21)25-24(32)26-23(28)17-12-18-8-6-7-11-22(18)31-2/h3-17H,1-2H3,(H2,25,26,28,32)/b17-12+",XOMQERYBMDFBAG-SFQUDFHCSA-N,Agonist,Agonist,,,,,pEC50,6.96,,6.92,EC50,120.0,,110.0,=,,,,21534610, GPR55,109,Q9Y2T6,Human,CID1172084,5564,,1172084,COc1ccc2c(c1)n1c(SCC(=O)Nc3scc(n3)c3ccc(cc3)F)nnc1c(c2)C,"InChI=1S/C23H18FN5O2S2/c1-13-9-15-5-8-17(31-2)10-19(15)29-21(13)27-28-23(29)33-12-20(30)26-22-25-18(11-32-22)14-3-6-16(24)7-4-14/h3-11H,12H2,1-2H3,(H,25,26,30)",NQAXYXKWUOWLNN-UHFFFAOYSA-N,Agonist,Agonist,,,,,pEC50,6.8,,6.74,EC50,180.0,,159.0,=,,,,21534610, GPR55,109,Q9Y2T6,Human,CID2440433,5565,,2440433,O=C(c1cc(ccc1N1CCCC1)S(=O)(=O)N(C)C)N1CCN(CC1)c1cccc(c1C)C,"InChI=1S/C25H34N4O3S/c1-19-8-7-9-23(20(19)2)28-14-16-29(17-15-28)25(30)22-18-21(33(31,32)26(3)4)10-11-24(22)27-12-5-6-13-27/h7-11,18H,5-6,12-17H2,1-4H3",VRSJAHQGJHDACS-UHFFFAOYSA-N,Agonist,Agonist,,,,,pEC50,6.6,,6.57,EC50,270.0,,250.0,=,,,,21534610, GPR55,109,Q9Y2T6,Human,"CP55,244",5568,,9844074,CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)C[C@H]2[C@H]1C[C@@H](CO)CC2)(C)C,"InChI=1S/C26H42O3/c1-4-5-6-7-12-26(2,3)20-10-11-22(25(29)15-20)24-16-21(28)14-19-9-8-18(17-27)13-23(19)24/h10-11,15,18-19,21,23-24,27-29H,4-9,12-14,16-17H2,1-3H3/t18-,19-,21+,23+,24-/m0/s1",ZAELPWSCABXXAB-NWXGMGMZSA-N,Agonist,Inverse agonist,,,,,pIC50,,8.3,,,,,,=,,,,21233197, GPR55,109,Q9Y2T6,Human,"CP55,667",5570,,4412255,CCCCCCC(c1ccc(c(c1)O)C1CC(O)CCC1CCCO)(C)C,"InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3",YNZFFALZMRAPHQ-UHFFFAOYSA-N,Antagonist,Inverse agonist,,,,,pIC50,,6.8,,,,,,=,,,,21233197, GPR55,109,Q9Y2T6,Human,CID16020046,6577,,16020046,Oc1cccc(c1)C1N(c2ccc(cc2)C(=O)O)C(=O)c2c1c(n[nH]2)c1ccc(cc1)C,"InChI=1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32)",VGUQVYZXABOXCX-UHFFFAOYSA-N,Antagonist,Antagonist,apparent pA2,,,,pA2,,7.3,,,,,,=,,,,23639801, GPR55,109,Q9Y2T6,Human,ML193,9967,,1261822,Cc1cc(C)c2c(c1)c(cc(n2)c1ccccn1)C(=O)Nc1ccc(cc1)S(=O)(=O)Nc1onc(c1C)C,"InChI=1S/C28H25N5O4S/c1-16-13-17(2)26-22(14-16)23(15-25(31-26)24-7-5-6-12-29-24)27(34)30-20-8-10-21(11-9-20)38(35,36)33-28-18(3)19(4)32-37-28/h5-15,33H,1-4H3,(H,30,34)",HTSLEZOTMYUPLU-UHFFFAOYSA-N,Antagonist,Antagonist,,,,,pIC50,,6.66,,IC50,,221.0,,=,,,,22091481, GPR55,109,Q9Y2T6,Human,"compound 3a [Badolato et al., 2019]",10345,,378629,ClC1=C(N2CCOCC2)C(=O)c2c(C1=O)c(O)ccc2O,"InChI=1S/C14H12ClNO5/c15-11-12(16-3-5-21-6-4-16)14(20)10-8(18)2-1-7(17)9(10)13(11)19/h1-2,17-18H,3-6H2",FTMCZTSKCXEXCO-UHFFFAOYSA-N,Agonist,Inverse agonist,,,,,,,,,,,,,=,,,,30996770, GPR55,109,Q9Y2T6,Human,MANSC (415-431),10539,Human,139600923,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)CC(=O)O)C(C)C)Cc1ccc(cc1)O)[C@H](CC)C)CC(=O)N)[C@H](CC)C)CC(C)C)Cc1ccc(cc1)O)CC(=O)O)CC(C)C)CCCN=C(N)N)CO)Cc1ccc(cc1)O)CCCN=C(N)N)N,"InChI=1S/C97H153N25O27/c1-13-51(10)77(93(146)115-67(42-56-27-33-59(126)34-28-56)89(142)120-76(50(8)9)92(145)117-70(45-75(131)132)90(143)122-79(95(148)149)53(12)15-3)119-73(128)46-107-81(134)68(43-72(100)127)116-94(147)78(52(11)14-2)121-88(141)64(39-49(6)7)111-85(138)65(40-54-23-29-57(124)30-24-54)113-87(140)69(44-74(129)130)114-84(137)63(38-48(4)5)110-83(136)62(22-19-37-106-97(103)104)109-91(144)71(47-123)118-86(139)66(41-55-25-31-58(125)32-26-55)112-82(135)61(21-18-36-105-96(101)102)108-80(133)60(99)20-16-17-35-98/h23-34,48-53,60-71,76-79,123-126H,13-22,35-47,98-99H2,1-12H3,(H2,100,127)(H,107,134)(H,108,133)(H,109,144)(H,110,136)(H,111,138)(H,112,135)(H,113,140)(H,114,137)(H,115,146)(H,116,147)(H,117,145)(H,118,139)(H,119,128)(H,120,142)(H,121,141)(H,122,143)(H,129,130)(H,131,132)(H,148,149)(H4,101,102,105)(H4,103,104,106)/t51-,52-,53-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,76-,77-,78-,79-/m0/s1",CCMVMLBWJFAFRO-IAMXVIFYSA-N,Agonist,Agonist,,,,,pEC50,,5.51,,EC50,,3090.0,,=,Determined in a dynamic mass redistribution (DMR) assay in Flp-In T-REx 293 cells expressing SNAP-tagged hGPR55.,,,31675498, GPR55,109,Q9Y2T6,Human,Chgb (511-532),10540,Rat,139600924,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)Cc1ccccc1)CC(=O)O)CO)CC(=O)N)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)N)CCCN=C(N)N)CC(C)C)C)CC(C)C)Cc1ccccc1)CC(=O)N)Cc1ccc(cc1)O)Cc1ccccc1)CC(=O)O)CC(C)C)CCC(=O)N,"InChI=1S/C127H181N31O34/c1-67(2)52-84(145-110(175)81(36-23-49-136-127(134)135)140-107(172)78(130)33-19-21-47-128)108(173)138-65-102(164)139-70(7)106(171)144-85(53-68(3)4)113(178)146-88(56-72-28-13-9-14-29-72)116(181)154-94(61-101(133)163)124(189)157-50-24-38-98(157)123(188)153-90(58-74-39-41-76(160)42-40-74)115(180)147-89(57-73-30-15-10-16-31-73)117(182)155-95(63-105(169)170)125(190)158-51-25-37-97(158)122(187)152-86(54-69(5)6)112(177)142-82(43-45-99(131)161)111(176)149-91(59-75-64-137-79-34-18-17-32-77(75)79)118(183)141-80(35-20-22-48-129)109(174)150-92(60-100(132)162)119(184)156-96(66-159)121(186)151-93(62-104(167)168)120(185)148-87(55-71-26-11-8-12-27-71)114(179)143-83(126(191)192)44-46-103(165)166/h8-18,26-32,34,39-42,64,67-70,78,80-98,137,159-160H,19-25,33,35-38,43-63,65-66,128-130H2,1-7H3,(H2,131,161)(H2,132,162)(H2,133,163)(H,138,173)(H,139,164)(H,140,172)(H,141,183)(H,142,177)(H,143,179)(H,144,171)(H,145,175)(H,146,178)(H,147,180)(H,148,185)(H,149,176)(H,150,174)(H,151,186)(H,152,187)(H,153,188)(H,154,181)(H,155,182)(H,156,184)(H,165,166)(H,167,168)(H,169,170)(H,191,192)(H4,134,135,136)/t70-,78-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-/m0/s1",USZLWOIXWADXRT-HXRUCQLXSA-N,Agonist,Agonist,,,,,pEC50,,5.62,,EC50,,2399.0,,=,Determined in a dynamic mass redistribution (DMR) assay in Flp-In T-REx 293 cells expressing SNAP-tagged hGPR55.,,,, GPR55,109,Q9Y2T6,Human,MSMB (91-114),10541,Human,139600925,NCCCC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)[C@H](CC)C)Cc1c[nH]c2c1cccc2)CCC(=O)O)CO)C(C)C)CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N)CC(=O)O)CCCCN)Cc1ccc(cc1)O)[C@H](CC)C)C(C)C)C(C)C,"InChI=1S/C127H204N30O39S2/c1-14-66(10)100-123(191)152-99(65(8)9)122(190)151-98(64(6)7)120(188)141-82(44-47-94(166)167)109(177)136-76(32-19-24-48-128)105(173)135-78(34-21-26-50-130)108(176)145-86(57-96(170)171)126(194)157-53-29-37-91(157)119(187)140-79(35-22-27-51-131)106(174)137-80(36-23-28-52-132)111(179)156-103(69(13)160)125(193)149-90(62-198-197-61-89(148-112(180)85(56-95(168)169)142-104(172)74(133)42-45-92(162)163)117(185)138-77(33-20-25-49-129)107(175)143-83(113(181)153-100)54-70-38-40-72(161)41-39-70)118(186)146-88(60-159)116(184)150-97(63(4)5)121(189)147-87(59-158)115(183)139-81(43-46-93(164)165)110(178)144-84(55-71-58-134-75-31-18-17-30-73(71)75)114(182)154-101(67(11)15-2)124(192)155-102(127(195)196)68(12)16-3/h17-18,30-31,38-41,58,63-69,74,76-91,97-103,134,158-161H,14-16,19-29,32-37,42-57,59-62,128-133H2,1-13H3,(H,135,173)(H,136,177)(H,137,174)(H,138,185)(H,139,183)(H,140,187)(H,141,188)(H,142,172)(H,143,175)(H,144,178)(H,145,176)(H,146,186)(H,147,189)(H,148,180)(H,149,193)(H,150,184)(H,151,190)(H,152,191)(H,153,181)(H,154,182)(H,155,192)(H,156,179)(H,162,163)(H,164,165)(H,166,167)(H,168,169)(H,170,171)(H,195,196)/t66-,67-,68-,69+,74-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,97-,98-,99-,100-,101-,102-,103-/m0/s1",JXASPFJVDIPKEB-XNSPQFCGSA-N,Agonist,Agonist,,,,,pEC50,,6.65,,EC50,,224.0,,=,Determined in a dynamic mass redistribution (DMR) assay in Flp-In T-REx 293 cells expressing SNAP-tagged hGPR55.,,,31675498, GPR55,109,Q9Y2T6,Human,SPAG11B (61-103),10542,Human,139600926,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)CC(=O)O)Cc1ccccc1)CC(C)C)CCC2)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CC(=O)N)[C@H](O)C)CO)[C@H](CC)C)CCCN=C(N)N)Cc1ccccc1)CO)CCCN=C(N)N)C)CCC(=O)O)CCCN=C(N)N)Cc1nc[nH]c1)CO)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CC(C)C)CC(C)C)CCCN=C(N)N)Cc1ccc(cc1)O)CCC(=O)N)Cc1nc[nH]c1)C,"InChI=1S/C215H330N68O58S2/c1-19-110(13)167(275-190(321)141(87-121-93-232-104-245-121)265-201(332)165(108(9)10)272-182(313)132(63-65-156(217)290)255-186(317)138(84-118-59-61-122(289)62-60-118)264-199(330)153-56-38-76-281(153)207(338)155-58-40-78-283(155)208(339)170(115(18)288)277-181(312)131(52-34-72-238-215(229)230)257-198(329)152-55-37-75-280(152)206(337)154-57-39-77-282(154)205(336)143(81-107(7)8)267-184(315)135(80-106(5)6)258-173(304)124(216)88-163(298)299)203(334)270-146(99-285)192(323)263-140(86-120-92-231-103-244-120)188(319)252-128(49-31-69-235-212(223)224)178(309)254-133(64-66-162(296)297)177(308)246-112(15)171(302)251-127(48-30-68-234-211(221)222)175(306)242-96-160(294)279-74-36-54-151(279)197(328)269-145(98-284)191(322)261-136(82-116-41-23-21-24-42-116)185(316)253-130(51-33-71-237-214(227)228)180(311)274-168(111(14)20-2)204(335)271-149-102-343-342-101-148(194(325)268-147(100-286)193(324)276-169(114(17)287)200(331)241-95-158(292)248-144(209(340)341)89-157(218)291)249-159(293)94-240-174(305)126(47-29-67-233-210(219)220)250-172(303)113(16)247-183(314)139(85-119-91-239-125-46-28-27-45-123(119)125)262-179(310)129(50-32-70-236-213(225)226)256-196(327)150-53-35-73-278(150)161(295)97-243-176(307)134(79-105(3)4)259-187(318)137(83-117-43-25-22-26-44-117)260-189(320)142(90-164(300)301)266-202(333)166(109(11)12)273-195(149)326/h21-28,41-46,59-62,91-93,103-115,124,126-155,165-170,239,284-289H,19-20,29-40,47-58,63-90,94-102,216H2,1-18H3,(H2,217,290)(H2,218,291)(H,231,244)(H,232,245)(H,240,305)(H,241,331)(H,242,306)(H,243,307)(H,246,308)(H,247,314)(H,248,292)(H,249,293)(H,250,303)(H,251,302)(H,252,319)(H,253,316)(H,254,309)(H,255,317)(H,256,327)(H,257,329)(H,258,304)(H,259,318)(H,260,320)(H,261,322)(H,262,310)(H,263,323)(H,264,330)(H,265,332)(H,266,333)(H,267,315)(H,268,325)(H,269,328)(H,270,334)(H,271,335)(H,272,313)(H,273,326)(H,274,311)(H,275,321)(H,276,324)(H,277,312)(H,296,297)(H,298,299)(H,300,301)(H,340,341)(H4,219,220,233)(H4,221,222,234)(H4,223,224,235)(H4,225,226,236)(H4,227,228,237)(H4,229,230,238)/t110-,111-,112-,113-,114+,115+,124-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,165-,166-,167-,168-,169-,170-/m0/s1",NZRXPCZWIFPFBB-SZWZVGMQSA-N,Agonist,Agonist,,,,,pEC50,,5.69,,EC50,,2042.0,,=,Determined in a real-time internalization TR-FRET assay in Flp-In T-REx 293 cells expressing SNAP-tagged hGPR55.,,,31675498, GPR55,109,Q9Y2T6,Human,CLUL1 (52-77),10543,Human,139600927,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](O)C)CO)CCSC)CC(C)C)CC(=O)N)[C@H](O)C)Cc1c[nH]cn1)CCC(=O)O)CCCCN)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC(C)C)CCCCN)CCC(=O)N)CCSC)CCCCN)CCSC)CCSC)CCC(=O)O)CCCN=C(N)N,"InChI=1S/C130H229N37O39S4/c1-19-68(9)100(163-96(174)62-142-124(200)102(71(12)169)165-121(197)89(57-66(5)6)157-105(181)70(11)135)125(201)155-77(32-23-27-49-133)108(184)148-80(35-39-94(136)172)110(186)152-84(43-52-207-15)114(190)146-78(33-24-28-50-134)118(194)164-101(69(10)20-2)126(202)156-87(46-55-210-18)116(192)153-85(44-53-208-16)115(191)151-82(37-41-98(177)178)112(188)147-79(34-29-51-141-130(138)139)109(185)144-75(30-21-25-47-131)106(182)149-81(36-40-97(175)176)111(187)145-76(31-22-26-48-132)107(183)150-83(38-42-99(179)180)113(189)159-90(59-74-61-140-64-143-74)122(198)166-103(72(13)170)127(203)160-91(60-95(137)173)120(196)158-88(56-65(3)4)119(195)154-86(45-54-209-17)117(193)162-93(63-168)123(199)167-104(73(14)171)128(204)161-92(129(205)206)58-67(7)8/h61,64-73,75-93,100-104,168-171H,19-60,62-63,131-135H2,1-18H3,(H2,136,172)(H2,137,173)(H,140,143)(H,142,200)(H,144,185)(H,145,187)(H,146,190)(H,147,188)(H,148,184)(H,149,182)(H,150,183)(H,151,191)(H,152,186)(H,153,192)(H,154,195)(H,155,201)(H,156,202)(H,157,181)(H,158,196)(H,159,189)(H,160,203)(H,161,204)(H,162,193)(H,163,174)(H,164,194)(H,165,197)(H,166,198)(H,167,199)(H,175,176)(H,177,178)(H,179,180)(H,205,206)(H4,138,139,141)/t68-,69-,70-,71+,72+,73+,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,100-,101-,102-,103-,104-/m0/s1",RVUJAIDUVQKVDU-OTFOMDLSSA-N,Agonist,Agonist,,,,,pEC50,,6.74,,EC50,,182.0,,=,Determined in a dynamic mass redistribution (DMR) assay in Flp-In T-REx 293 cells expressing SNAP-tagged hGPR55.,,,31675498,